Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer
Xavier Guitart, Gemma Navarro, Estefanía Moreno, et al.
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 417-429
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Comorbidities, treatment, and pathophysiology in restless legs syndrome
Claudia Trenkwalder, Richard P. Allen, Birgit Högl, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 11, pp. 994-1005
Closed Access | Times Cited: 221
Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
Sergi Ferré
Psychopharmacology (2016) Vol. 233, Iss. 10, pp. 1963-1979
Open Access | Times Cited: 187
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Viñals, Estefanía Moreno, Laurence Lanfumey, et al.
PLoS Biology (2015) Vol. 13, Iss. 7, pp. e1002194-e1002194
Open Access | Times Cited: 182
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
Pharmacology & Therapeutics (2018) Vol. 192, pp. 20-41
Closed Access | Times Cited: 177
Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 149
Allosteric interactions between agonists and antagonists within the adenosine A 2A receptor-dopamine D 2 receptor heterotetramer
Jordi Bonaventura, Gemma Navarro, Verònica Casadó-Anguera, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 27
Open Access | Times Cited: 139
The GPCR heterotetramer: challenging classical pharmacology
Sergi Ferré
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 3, pp. 145-152
Open Access | Times Cited: 112
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
An update on the physiological and therapeutic relevance of GPCR oligomers
Batoul Farran
Pharmacological Research (2017) Vol. 117, pp. 303-327
Closed Access | Times Cited: 106
Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling
Óscar Solís, José Rubén García-Montes, Aldo Efrain González-Granillo, et al.
Cerebral Cortex (2015), pp. bhv231-bhv231
Open Access | Times Cited: 98
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis
Thomas M. Keck, William S. John, Paul W. Czoty, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 14, pp. 5361-5380
Open Access | Times Cited: 96
Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer
Sergi Ferré, Jordi Bonaventura, Dardo Tomasi, et al.
Neuropharmacology (2015) Vol. 104, pp. 154-160
Open Access | Times Cited: 91
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
Samuele Maramai, Sandra Gemma, Simone Brogi, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 83
Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome
Sergi Ferré, César Quiroz, Xavier Guitart, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 81
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist
Marta Sánchez‐Soto, Alessandro Bonifazi, Ning Cai, et al.
Molecular Pharmacology (2016) Vol. 89, Iss. 4, pp. 457-466
Open Access | Times Cited: 73
Revealing G‐protein‐coupled receptor oligomerization at the single‐molecule level through a nanoscopic lens: methods, dynamics and biological function
Marco Scarselli, Paolo Annibale, Peter J. McCormick, et al.
FEBS Journal (2015) Vol. 283, Iss. 7, pp. 1197-1217
Open Access | Times Cited: 71
Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine
Gemma Navarro, César Quiroz, David Moreno‐Delgado, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 17, pp. 6639-6653
Open Access | Times Cited: 69
Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
Dasiel O. Borroto‐Escuela, David Rodríguez, Wilber Romero-Fernández, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 69
Control of glutamate release by complexes of adenosine and cannabinoid receptors
Attila Köfalvi, Estefanía Moreno, Arnau Cordomí, et al.
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 68
Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation
Christopher J. Earley, George R. Uhl, Stefan Clemens, et al.
Sleep Medicine (2016) Vol. 31, pp. 71-77
Open Access | Times Cited: 61
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferré, Francisco Ciruela, Carmen Dessauer, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107977-107977
Open Access | Times Cited: 49
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Fangyi Zhao, Ziqian Cheng, Jingjing Piao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
G Protein–Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches
Henry F. Vischer, Marián Castro, Jean‐Philippe Pin
Molecular Pharmacology (2015) Vol. 88, Iss. 3, pp. 561-571
Open Access | Times Cited: 63
Cortico-striatal circuits: Novel therapeutic targets for substance use disorders
Alexxai V. Kravitz, Dardo Tomasi, Kimberly H. LeBlanc, et al.
Brain Research (2015) Vol. 1628, pp. 186-198
Open Access | Times Cited: 60
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum
Estefanía Moreno, Anna Chiarlone, Mireia Medrano, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 5, pp. 964-977
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top